Yasuhiro Arakawa

559 total citations
37 papers, 380 citations indexed

About

Yasuhiro Arakawa is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yasuhiro Arakawa has authored 37 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yasuhiro Arakawa's work include Cancer therapeutics and mechanisms (8 papers), Cancer Treatment and Pharmacology (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Yasuhiro Arakawa is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Cancer Treatment and Pharmacology (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Yasuhiro Arakawa collaborates with scholars based in Japan, United States and France. Yasuhiro Arakawa's co-authors include Hisashi Yamada, Keisuke Aiba, Shinobu Saito, Junko Horiguchi‐Yamada, Yves Pommier, Tadashi Kobayashi, Masao Kobayashi, Nitin Roper, Suresh Kumar and Hideaki Suzuki and has published in prestigious journals such as Gastroenterology, Cancer Research and Annals of Oncology.

In The Last Decade

Yasuhiro Arakawa

33 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuhiro Arakawa Japan 11 159 150 94 90 86 37 380
Linda Cerbone Italy 13 149 0.9× 183 1.2× 100 1.1× 167 1.9× 233 2.7× 34 480
Begoña Pérez‐Valderrama Spain 13 148 0.9× 155 1.0× 106 1.1× 88 1.0× 220 2.6× 50 405
Valentina Tateo Italy 10 205 1.3× 114 0.8× 96 1.0× 106 1.2× 150 1.7× 36 437
Eugenio Fiorentino Italy 15 149 0.9× 209 1.4× 177 1.9× 176 2.0× 156 1.8× 41 572
Yanlong Yang China 14 127 0.8× 188 1.3× 123 1.3× 99 1.1× 133 1.5× 27 441
Toshikazu Okaneya Japan 12 124 0.8× 141 0.9× 47 0.5× 124 1.4× 152 1.8× 51 423
Kyrillus S. Shohdy Egypt 12 197 1.2× 88 0.6× 114 1.2× 59 0.7× 213 2.5× 39 440
Hari A. Deshpande United States 10 136 0.9× 120 0.8× 39 0.4× 57 0.6× 90 1.0× 46 363
Hironori Betsunoh Japan 11 103 0.6× 153 1.0× 70 0.7× 66 0.7× 112 1.3× 24 362
Takako Suda Japan 11 136 0.9× 117 0.8× 53 0.6× 106 1.2× 70 0.8× 25 391

Countries citing papers authored by Yasuhiro Arakawa

Since Specialization
Citations

This map shows the geographic impact of Yasuhiro Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Arakawa more than expected).

Fields of papers citing papers by Yasuhiro Arakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuhiro Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Arakawa. The network helps show where Yasuhiro Arakawa may publish in the future.

Co-authorship network of co-authors of Yasuhiro Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Arakawa. A scholar is included among the top collaborators of Yasuhiro Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Arakawa. Yasuhiro Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Suresh, Yasuhiro Arakawa, Nitin Roper, et al.. (2023). Preclinical Models of Adrenocortical Cancer. Cancers. 15(11). 2873–2873. 11 indexed citations
2.
Jo, Ukhyun, Yasuhiro Arakawa, Astrid Zimmermann, et al.. (2023). Abstract LB301: Molecular pharmacology and broad synergy of the novel ATR inhibitor M1774 with DNA damaging anticancer agents. Cancer Research. 83(8_Supplement). LB301–LB301. 1 indexed citations
3.
Jo, Ukhyun, Yasuhisa Murai, Keli Agama, et al.. (2022). TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor. Molecular Cancer Therapeutics. 21(7). 1090–1102. 30 indexed citations
4.
Murai, Yasuhisa, Ukhyun Jo, Yasuhiro Arakawa, Naoko Takebe, & Yves Pommier. (2022). SLFN11’s surveillance role in protein homeostasis. Oncoscience. 9. 35–37.
5.
Nishikawa, Katsunori, Yasuhiro Arakawa, Akira Matsumoto, et al.. (2020). Five-year Outcomes of Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Oesophagectomy in Oesophageal Cancer. Anticancer Research. 40(10). 5829–5835. 1 indexed citations
6.
Suzuki, Kazuhito, Takeshi Saito, Yasuhiro Arakawa, et al.. (2019). Concurrent immunoglobulin G-lambda type multiple myeloma and mixed cellularity classical Hodgkin lymphoma: A case report. Journal of Infection and Chemotherapy. 26(1). 115–118. 1 indexed citations
7.
Hayashi, Kazumi, Eijiro Nagasaki, Koji Nakada, et al.. (2017). Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2. Journal of Infection and Chemotherapy. 24(4). 298–301. 4 indexed citations
8.
Arakawa, Yasuhiro, Miho Tamura, Keisuke Aiba, et al.. (2017). Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report. Oncology Letters. 14(3). 3039–3042. 24 indexed citations
9.
Suzuki, Kazuhito, et al.. (2016). Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL. Anti-Cancer Drugs. 27(8). 756–765. 10 indexed citations
10.
Arakawa, Yasuhiro, Miho Tamura, Keisuke Aiba, et al.. (2015). Early measurement of urinary N-acetyl-β-glucosaminidase helps predict severe hyponatremia associated with cisplatin-containing chemotherapy. Journal of Infection and Chemotherapy. 21(7). 502–506. 7 indexed citations
11.
Akiyama, Masaharu, Kentaro Yokoi, Yasuhiro Arakawa, et al.. (2015). Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome. International Journal of Hematology. 102(6). 723–728. 10 indexed citations
12.
Arakawa, Yasuhiro, et al.. (2013). Three missense mutations of DNA topoisomerase I in highly camptothecin-resistant colon cancer cell sublines. Oncology Reports. 30(3). 1053–1058. 14 indexed citations
13.
Nagasaki, Eijiro, Masami Yuda, Yasuhiro Arakawa, et al.. (2012). Complete response of esophageal small cell carcinoma amrubicin treatment. Journal of Infection and Chemotherapy. 19(4). 770–775. 4 indexed citations
14.
Arakawa, Yasuhiro & Keisuke Aiba. (2012). [Predictive biomarkers for response to irinotecan, platinum drugs, and taxanes].. PubMed. 39(11). 1608–12. 1 indexed citations
15.
Kobayashi, Tadashi, Tamotsu Ichiba, Yasuhiro Arakawa, et al.. (2012). Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review. Breast Cancer. 19(3). 218–237. 91 indexed citations
16.
Arakawa, Yasuhiro, Shinobu Saito, Hisashi Yamada, & Keisuke Aiba. (2009). Simultaneous treatment with camptothecin and valproic acid suppresses induction of Bcl-XL and promotes apoptosis of MCF-7 breast cancer cells. APOPTOSIS. 14(9). 1076–1085. 16 indexed citations
17.
Yamada, Hisashi, Satsuki Iwase, Yasuhiro Arakawa, et al.. (2007). Segregation of megakaryocytic or erythroid cells from a megakaryocytic leukemia cell line (JAS-R) by adhesion during culture. Leukemia Research. 31(11). 1537–1543. 4 indexed citations
18.
Suzuki, Hideaki, Yasuhiro Arakawa, Masaki Ito, et al.. (2007). MLF1-interacting protein is mainly localized in nucleolus through N-terminal bipartite nuclear localization signal.. PubMed. 27(3B). 1423–30. 8 indexed citations
19.
20.
Iwase, Satsuki, Nobutake Akiyama, Shinobu Saito, et al.. (2003). Both NUP98/TOP1 and TOP1/NUP98 transcripts are detected in a de novo AML with t(11;20)(p15;q11). Genes Chromosomes and Cancer. 38(1). 102–105. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Cerbone Breakdown of academic impact, for papers by Begoña Pérez‐Valderrama Breakdown of academic impact, for papers by Valentina Tateo Breakdown of academic impact, for papers by Eugenio Fiorentino Breakdown of academic impact, for papers by Yanlong Yang Breakdown of academic impact, for papers by Toshikazu Okaneya Breakdown of academic impact, for papers by Kyrillus S. Shohdy Breakdown of academic impact, for papers by Hari A. Deshpande Breakdown of academic impact, for papers by Hironori Betsunoh Breakdown of academic impact, for papers by Takako Suda
Rankless by CCL
2026